Delfi Researchers and Founders to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting - PR Newswire

/PRNewswire/ -- Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection, will...

Delfi Founder and CEO Elected to the Fellows of the AACR Academy Class of 2022 BALTIMORE, April 4, 2022 /PRNewswire/ -- Delfi Diagnostics, a pioneering developer of a new class of high-performance, … [+2769 chars]

full article...